Your browser doesn't support javascript.
loading
Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group.
Katodritou, Eirini; Terpos, Evangelos; Delimpasi, Sossana; Kotsopoulou, Maria; Michalis, Eurydiki; Vadikolia, Chrysanthi; Kyrtsonis, Marie-Christine; Symeonidis, Argiris; Giannakoulas, Nikolaos; Vadikolia, Chrissa; Michael, Michalis; Kalpadakis, Christina; Gougopoulou, Theodora; Prokopiou, Chrystalla; Kaiafa, Georgia; Christoulas, Dimitrios; Gavriatopoulou, Maria; Giannopoulou, Evlampia; Labropoulou, Vasiliki; Verrou, Evgenia; Kastritis, Efstathios; Konstantinidou, Pavlina; Anagnostopoulos, Achilles; Dimopoulos, Meletios A.
Afiliação
  • Katodritou E; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece. eirinikatodritou@gmail.com.
  • Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Delimpasi S; Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece.
  • Kotsopoulou M; Department of Haematology, Metaxa Cancer Hospital, Piraeus, Greece.
  • Michalis E; Department of Hematology, "G. Gennimatas" General Hospital, Athens, Greece.
  • Vadikolia C; Department of Hematology and Bone Marrow Transplantation Unit, George Papanikolaou Hospital, Thessaloniki, Greece.
  • Kyrtsonis MC; First Department of Propaedeutic Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Symeonidis A; Department of Internal Medicine, Division of Hematology, University of Patras Medical School, Patras, Greece.
  • Giannakoulas N; Department of Hematology, School of Medicine, University of Thessaly, Larisa, Greece.
  • Vadikolia C; Department of Hematology, 424 General Military Hospital, Thessaloniki, Greece.
  • Michael M; Department of Hematology, Nicosia General Hospital, Nicosia, Cyprus.
  • Kalpadakis C; Department of Hematology, School of Medicine, University of Crete, Heraklion, Greece.
  • Gougopoulou T; Department of Hematology, University of Ioannina School of Medicine, Ioannina, Greece.
  • Prokopiou C; Department of Hematology, New General Limassol Hospital, Limassol, Cyprus.
  • Kaiafa G; Hematology Department, AHEPA University Hospital, Thessaloniki, Greece.
  • Christoulas D; Department of Hematology, 251 General Air Force Hospital, Athens, Greece.
  • Gavriatopoulou M; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Giannopoulou E; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece.
  • Labropoulou V; Department of Internal Medicine, Division of Hematology, University of Patras Medical School, Patras, Greece.
  • Verrou E; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece.
  • Kastritis E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Konstantinidou P; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece.
  • Anagnostopoulos A; Department of Hematology and Bone Marrow Transplantation Unit, George Papanikolaou Hospital, Thessaloniki, Greece.
  • Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Blood Cancer J ; 8(3): 31, 2018 03 09.
Article em En | MEDLINE | ID: mdl-29523783
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Plasmocitária / Transplante de Células-Tronco / Bortezomib Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Plasmocitária / Transplante de Células-Tronco / Bortezomib Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article